Have $2,000? 3 Top Robotics Stocks to Buy and Hold for at Least a Decade

While industrial manufacturing remains a dominant segment, robotics adoption is rapidly expanding into healthcare (e.g., ...
Seeking Alpha

Intuitive’s da Vinci 5 Surgical System Receives CE Mark

SUNNYVALE, Calif., July 02, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...
Nasdaq

Intuitive Receives FDA Clearance for da Vinci SP Surgical System for Transanal Colorectal Procedures

Intuitive's da Vinci SP surgical system receives FDA clearance for transanal local resection, enhancing minimally invasive colorectal surgery options. Intuitive, a leader in robotic-assisted surgery, ...
Nasdaq

Intuitive Announces FDA Clearance of Fifth-Generation Robotic System, da Vinci 5

SUNNYVALE, Calif., March 14, 2024 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, announced today that ...
Seeking Alpha

Intuitive expands AI and advanced imaging integration in Ion Endoluminal System

SUNNYVALE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ:ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced that ...
Insider Monkey

Intuitive Surgical (ISRG) Surged on Excitement Over its New Robotic System

Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund declined 2.55% ...
Forbes

How Much Can Intuitive Surgical's System Revenue Grow Over The Next Three Years?

Intuitive Surgical (NASDAQ:ISRG) manufactures and sells robotic surgical systems. Its primary device is the da Vinci Surgical System, which helps surgeons perform minimally invasive surgeries through ...
Forbes

Intuitive Surgical Beats Expectations, Driven By da Vinci System

Intuitive Surgical again beat revenue and earnings expectations, propelled by its da Vinci robotic surgical systems, when it reported its second quarter performance after the market closed Thursday.